Physician

Kruti Patel Dajee, M.D.

According to 2025 Medicare claims, Kruti Dajee, M.D. (NPI: 1043506215) practices ophthalmology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Collin, TX. This provider's primary affiliated billing organization is KRUTI DAJEE M.D. P.A. (NPI: 1790316701; TIN: 844474175) and primary practice location at 75071-4915. Dajee is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Dajee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 770 traditional Medicare patients, billed 38,641 HCPCS/CPT codes, and received $2,188,226 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 424 prescription claims across 139 beneficiaries totaling $9,887 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,705 to $2,188,226. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,209 and ending at $9,887. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $2,705 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $42,602 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $64,442 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $250,416 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $340,316 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $191,908 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $827,093 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,192,203 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,632,133 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,188,226 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151820$2,705
2016356758$42,602
2017359755$64,442
20182891,882$250,416
20193592,653$340,316
20202252,080$191,908
20215385,685$827,093
20226877,965$1,192,203
202380016,084$1,632,133
202477038,641$2,188,226

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$48K$96K2015 Drug cost: $5,209 (USD; Tot_Drug_Cst)2016 Drug cost: $19,102 (USD; Tot_Drug_Cst)2017 Drug cost: $95,964 (USD; Tot_Drug_Cst)2018 Drug cost: $31,022 (USD; Tot_Drug_Cst)2019 Drug cost: $18,914 (USD; Tot_Drug_Cst)2020 Drug cost: $5,380 (USD; Tot_Drug_Cst)2021 Drug cost: $12,760 (USD; Tot_Drug_Cst)2022 Drug cost: $13,468 (USD; Tot_Drug_Cst)2023 Drug cost: $15,568 (USD; Tot_Drug_Cst)2024 Drug cost: $9,887 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151845$5,209
20162042$19,102
2017183715$95,964
2018107374$31,022
201975270$18,914
20203692$5,380
202180261$12,760
2022122385$13,468
2023143445$15,568
2024139424$9,887

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1181,142$652
67028Injection of drug into eye2621,301$100
92014Established patient complete exam of visual system6781,813$94
92134Imaging of retina7622,373$31
92201Extended exam of the back part of the eye with retinal drawing153155$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1456,102$6,150
MoxifloxacinMoxifloxacin Hcl861,215$2,002
ValacyclovirValacyclovir Hcl21866$859
Acetaminophen-CodeineAcetaminophen With Codeine5186$149
LatanoprostLatanoprost281,463$137

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$290Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kruti Patel Dajee, M.D.?

Tedicare shows public-source Medicare data for Kruti Patel Dajee, M.D. (NPI 1043506215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kruti Patel Dajee, M.D. have ACO affiliation data?

Kruti Patel Dajee, M.D. is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Kruti Patel Dajee, M.D.?

Kruti Patel Dajee, M.D. is linked to KRUTI DAJEE M.D. P.A. (billing NPI 1790316701) in the available physician profile data.

Does Kruti Patel Dajee, M.D. have Open Payments data?

Kruti Patel Dajee, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.